Icecure Medical Ltd (NASDAQ:ICCM) has seen 0.45 million shares traded in the recent trading session. The company, currently valued at $84.29M, closed the recent trade at $1.49 per share which meant it lost -$0.04 on the day or -2.61% during that session. The ICCM stock price is -9.4% off its 52-week high price of $1.63 and 67.79% above the 52-week low of $0.48.
The consensus among analysts is that Icecure Medical Ltd (ICCM) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.07.
Icecure Medical Ltd (NASDAQ:ICCM) trade information
Sporting -2.61% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ICCM stock price touched $1.49 or saw a rise of 10.24%. Year-to-date, Icecure Medical Ltd shares have moved 35.45%, while the 5-day performance has seen it change 11.19%. Over the past 30 days, the shares of Icecure Medical Ltd (NASDAQ:ICCM) have changed 22.13%.
Wall Street analysts have a consensus price target for the stock at $2.5, which means that the shares’ value could jump 40.4% from the levels at last check today. The projected low price target is $2.5 while the price target rests at a high of $2.5. In that case, then, we find that the latest price level in today’s session is -67.79% off the targeted high while a plunge would see the stock gain -67.79% from the levels at last check today.
Icecure Medical Ltd (ICCM) estimates and forecasts
The company’s shares have gained 152.54% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 8.05%.
2 analysts offering their estimates for the company have set an average revenue estimate of 1.07M for the current quarter. 2 have an estimated revenue figure of 952.5k for the next ending quarter. Year-ago sales stood 1.25M and 743k respectively for this quarter and the next, and analysts expect sales will shrink by -14.94% for the current quarter and 8.05% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -0.26% over the past 5 years. Earnings growth for 2025 is a modest 11.46% while over the next 5 years, the company’s earnings are expected to increase by 27.89%.
ICCM Dividends
Icecure Medical Ltd is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Icecure Medical Ltd (NASDAQ:ICCM)’s Major holders
The top two institutional holders are CITADEL ADVISORS LLC with over 0.17 million shares worth more than $0.13 million. As of 2024-06-30, CITADEL ADVISORS LLC held 0.3627% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 66400.0 shares as of 2024-06-30. The firm’s total holdings are worth over $49136.0 and represent 0.1421% of shares outstanding.
